| Literature DB >> 30365564 |
Natasha Housseine1,2,3, Marieke C Punt1,2, Joyce L Browne2, Tarek Meguid3,4, Kerstin Klipstein-Grobusch2,5, Barbara E Kwast6, Arie Franx1, Diederick E Grobbee2, Marcus J Rijken1,2.
Abstract
BACKGROUND: The majority of the five million perinatal deaths worldwide take place in low-resource settings. In contrast to high-resource settings, almost 50% of stillbirths occur intrapartum. The aim of this study was to synthesise available evidence of strategies for foetal surveillance in low-resource settings and associated neonatal and maternal outcomes, including barriers to their implementation. METHODS ANDEntities:
Mesh:
Year: 2018 PMID: 30365564 PMCID: PMC6203373 DOI: 10.1371/journal.pone.0206295
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Fig 1Flow diagram of search results.
Quality assessment of randomised controlled trials (n = 5).
| Randomised controlled trial | Intervention | Population | Sequence generation | Allocation concealment | Blinding of participant/ researcher | Selection of study population | Completeness of data | Origin of data | Clear definition of outcome? | Confounders taken into account? |
|---|---|---|---|---|---|---|---|---|---|---|
| Byaruhanga et al. 2015, Uganda [ | Wind-up, Doppler vs Pinard | 1971, singleton, | Unclear risk | Unclear risk | High risk | Low risk | Low risk | Low risk | Low risk | High risk |
| Fahdhy et al. 2005 Indonesia [ | WHO partograph and training | 625 low risk | Low risk | Low risk | High risk | High risk | Low risk | Low risk | Low risk | Unclear risk |
| Madaan et al. 2006 India [ | IA vs Continuous CTG | 100 post caesarean section singleton | Unclear risk | Unclear risk | High risk | Low risk | Low risk | Low risk | Low risk | Unclear risk |
| Mahomed et al. 1994, Zimbabwe [ | Intermittent CTG, Doppler, Pinard | 1255 singleton, cephalic, >37weeks, mixed-risk | Unclear risk | Low risk | High risk | Low risk | Low risk | Low risk | Low risk | Low risk |
| WHO, 1994 & Lennox 1998 Southeast Asia [ | WHO Partograph | 35 484, mixed-risk | Unclear risk | Unclear risk | High risk | Low risk | Low risk | Low risk | Low risk | Unclear risk |
Colour coding: Green = Low risk, Red = High risk and Yellow = Unclear risk. Abbreviations: CTG = Cardiotocography, IA = Intermittent Auscultation
*Clustered randomised control trial
Foetal monitoring methods as predictors of birth outcomes.
| Method | Predicts perinatal outcomes/foetal distress | Improves perinatal outcomes | Predicts mode of delivery | Increases operative deliveries | Improves | ||
|---|---|---|---|---|---|---|---|
| Admission test | CTG(n = 7) | ||||||
| IA (Doppler, n = 1)) | |||||||
| Admission AFI (n = 1) | |||||||
| FAST (n = 3) | |||||||
| rBPP(n = 1) | |||||||
| UADV(n = 2) | |||||||
| Ongoing intrapartum foetal monitoring | FHR | IA Pinard(n = 6) REFERENCE | |||||
| IA Doppler(n = 3) | |||||||
| CTG(n = 11) | |||||||
| Partograph(n = 5) | |||||||
| Adjunctive tests | MSAF(n = 7) | ||||||
| FSST(n = 1) | |||||||
| FBS(n = 1) | |||||||
| FPO(n = 1) | |||||||
| UADV(n = 1) | |||||||
Green = Yes; Red = No; Orange = Unclear (i.e. outcome not reported or the evidence conflicts across studies). AFI = Amniotic fluid index, CTG = cardiotocograph, FAST = Foetal acoustic stimulation test, FBS = Foetal blood sampling, FPO = Foetal pulse oximetry, FSST = Foetal scalp stimulation test, MSAF = Meconium-staining amniotic fluid, rBPP = rapid Biophysical Profile, UADV = Umbilical artery Doppler velocity
1Perinatal outcomes any of the following: Apgar score at 1 or 5 minutes, umbilical cord blood pH/gases, need for neonatal resuscitation, stillbirth (intrapartum/fresh), neonatal deaths before discharge/within 24hours, admission to neonatal care unit, hypoxic-ischaemic encephalopathy
2Pinard was used as a reference test for which Doppler and CTG were compared to.
Quality assessment of the observational studies (n = 32).
| Cohort studies | Method/ strategy | Population character-istics | Selection process | Compar-ability | Exposure | Cross-sectional studies | Method/ strategy | Population character-istics | Selection process | Compar-ability | Outcome |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aboulghar et al. 2013, Egypt [ | CTG | High risk | 4 | 0 | 2 | Adanikin et al. 2016 Nigeria [ | IA | Mixed-risk | 4 | 2 | 2 |
| Bakr et al. 2005 Egypt [ | FPO vs FBS | Unclear | 4 | 0 | 2 | Bolbol-Haghighi et al. 2015, Iran [ | Partograph | Low risk | 4 | 0 | 2 |
| Chittacharoen et al. 2000, Thailand [ | FAST and Admission CTG | High risk | 4 | 0 | 3 | Ogwang et al. 2009, Uganda [ | Partograph | Unclear, | 4 | 0 | 2 |
| Chittacharoen et al. 1997, Thailand [ | FAST | Unclear | 4 | 0 | 3 | Oladapo et al. 2009, Nigeria [ | IA and MSAF | Mixed-risk | 4 | 2 | 2 |
| David et al. 2014 India [ | Admission CTG | Low risk | 4 | 0 | 2 | Parveen et al. 2010, Pakistan [ | CTG and MSAF | Low risk | 5 | 0 | 1 |
| Duhan et al. 2010 India [ | MSAF and CTG | Unclear | 3 | 1 | 2 | Tasnim et al. 2009, Pakistan [ | CTG | Mixed-risk | 4 | 0 | 2 |
| Goldenberg et al. 2013, Multi-country [ | Admission IA(Doppler) | Unclear | 4 | 0 | 2 | ||||||
| Goonewardene et al. 2011, Sri Lanka [ | FAST and Admission CTG | Low risk | 4 | 0 | 2 | Bogdanovic et al. 2014, Bosnia [ | CTG | Unclear | 2 | 0 | 3 |
| Gupta et al. 1997 India, [ | MSAF | Mixed-risk | 3 | 0 | 2 | ||||||
| Howarth et al. 1992, South Africa [ | UADV | Unclear | 4 | 0 | 3 | ||||||
| Kulkarni et al. 1998 India [ | Admission CTG | High risk | 4 | 0 | 2 | ||||||
| Kushtagi et al. 2011, India [ | Admission AFI | Mixed-risk | 4 | 0 | 3 | ||||||
| Langli Ersdal et al. 2012, Tanzania [ | IA | Mixed-risk | 4 | 2 | 2 | ||||||
| Odendaal et al. 1977, South Africa [ | CTG | unclear | 4 | 2 | 2 | ||||||
| Odendaal et al. 1994, South Africa [ | CTG | High risk | 4 | 2 | 2 | ||||||
| Odongo et al. 2010 Kenya [ | CTG and MSAF | Unclear | 3 | 1 | 2 | ||||||
| Rahman et al. 2012 India [ | Admission CTG | Mixed risk | 4 | 2 | 2 | ||||||
| Rathore et al. 2011 India [ | FSST, IA and MSAF | High risk | 4 | 2 | 2 | ||||||
| Raouf et al. 2015 Iran[ | CTG | Low risk | 3 | 0 | 2 | ||||||
| Rotich et al. 2006 Kenya [ | IA and MSAF | Mixed-risk | 3 | 2 | 3 | ||||||
| Roy et al. 2008 India [ | CTG | Unclear | 4 | 0 | 3 | ||||||
| Shaktivardhan et al. 2009, India [ | Admission CTG | High risk | 4 | 0 | 2 | ||||||
| Stuart et al. 1993 South Africa [ | UADV | High risk | 4 | 0 | |||||||
| Tongprasert et al. 2006 Thailand [ | rBPP | Mixed-risk | 4 | 0 | 3 |
Colour coding: Green = Low -, Red = High—and Yellow = Intermediate risk of bias. Maximum points to be allocated (Cohort/ cross-sectional/ case-control): Selection process (4/5/4), Comparability (2/2/2), Outcome (3/3/-), Exposure (-/-/3). AFI = Amniotic fluid index, CTG = cardiotocograph, FAST = Foetal acoustic stimulation test, FBS = Foetal blood sampling, FPO = Foetal pulse oximetry, FSST = Foetal scalp stimulation test, MSAF = Meconium-staining amniotic fluid, NST = Non-stress test, rBPP = rapid Biophysical Profile, UADV = Umbilical artery Doppler velocity
*Pregnancy risk determination was based either: author’s specific mention of “low risk” and “high risk” pregnancies OR based on maternal and foetal risk factors described in the text. If no information available on maternal factors for “singleton, cephalic, >37” pregnancies the risk was status was defined as unclear.
SWOT analysis of methods of intrapartum foetal monitoring.
| Strengths | Weaknesses | Opportunities | Threats | |
|---|---|---|---|---|
| Detection of non-viable foetuses[ | False results due to poor equipment [ | Allows planning for safer delivery if intrauterine foetal death (on admission)[ | Limited human resources[ | |
| Lower cost and sustainable[ | Cannot detect subtle abnormalities or changes in FHR e.g. baseline variability[ | Can be used as an intrapartum stillbirth indicator for monitoring quality improvement of care for interventions (on admission)[ | Not always used on admission/intrapartum[ | |
| Can detect ir/regular rhythms, accelerations and decelerations[ | Difficult to use, time-consuming and labour intensive[ | Training may improve performance[ | False results due poorly trained staff[ | |
| Allows mobility of the women[ | Uncomfortable for the mother and staff (Pinard)[ | Promotes ‘‘hands-on” support to the labouring woman[ | Lack of foetal monitoring protocol[ | |
| Requires no additional resources/electricity (Pinard/wind-up Doppler)[ | Maternal heart rate may occasionally be counted[ | Non-adherence to frequency, duration of monitoring and documentation[ | ||
| Device easy to use with minimal training[ | Delays in action taking (long diagnosis to delivery time) [ | |||
| Audible to both mother and caregiver (even in noisy labour wards) [ | Unavailability of operative delivery[ | |||
| Unavailability of FBS and cord blood analysis to confirm foetal compromise[ | ||||
| May require repair and additional resources (Doppler)[ | ||||
| Responsible of large proportion of CS are due to suspected foetal distress[ | ||||
| Non-invasive(external) [ | Associated with high false positivity for foetal distress[ | Can be used intermittently during labour [ | Potential increase in unnecessary interventions (e.g. caesarean section)[ | |
| Able to detect subtle changes in FHR e.g. baseline variability [ | Low inter-observer agreement[ | Costly and requires maintenance [ | ||
| Several pathological features are predictive of foetal acidosis | Susceptible to technical and mechanical failure resulting in poor quality of traces and interpretation[ | Non-adherence of staff to protocol[ | ||
| Limited or unavailability of CTG machine[ | ||||
| Delays in action taking (long diagnosis to delivery time) [ | ||||
| No facility to perform FBS[ | ||||
| Unstable electricity supply[ | ||||
| Medicolegal climate[ | ||||
| Contraction may impair maternal perception of foetal movement[ | ||||
| Non-/less- invasive[ | Poor maternal perception of subtle foetal movement[ | Safer to use in over-distended and scarred uterus [ | ||
| Fast, simple and cheaper[ | Can be used to increase diagnostic accuracy of FHR monitoring: IA [ | |||
| No additional device necessary (scalp stimulation)[ | Screening tool in early labour[ | |||
| No rupture of membranes required[ | ||||
| Simple and fast[ | Not adequate as a screening test[ | May be used as an additional back up test[ | ||
| Relatively inexpensive[ | ||||
| Feasible and no discomfort in labour[ | Not useful in detecting foetal acidosis during labour[ | |||
| Non-invasive and simple[ | ||||
| A warning sign that closer attention is warranted[ | Highly unreliable when used alone[ | More reliable when combined with FHR monitoring (IA [ | Association with an increase in caesarean[ | |
| Require ruptured membranes[ | ||||
| FPO is less invasive than FBS[ | Recordings take 30 minutes (time-consuming)[ | May decrease unnecessary interventions (e.g. CS) [ | ||
| FPO may be an alternative to foetal blood sampling[ | ||||
| Provides recording of the foetal and maternal parameters[ | Too detailed[ | Encourages supportive care to women [ | Incorrect and/ incompletion of partographs: e.g. due to lack of time, motivation, human resources[ | |
| Single page[ | Requires intensive and repeated training[ | Helps interpret findings[ | Loss of partographs[ | |
| Visual presentation with clear overview of progress of labour[ | Applicable mostly in first stage of labour[ | Training and supervision improves use[ | The need for photocopying[ | |
| Accompanied by management protocol[ | Helps communication and hand-over of patients between staff [ | Lack of updated versions[ | ||
| Permits evaluation of quality of care[ | Removal of latent phase causes incomplete follow-up and difficulty in diagnosing prolonged latent phase[ | |||
| Timely referral[ | Unavailability of guidelines in labour wards[ | |||
| Early diagnosis of complications and early decision making[ | Non-adherence to protocol[ | |||
| Labour wards can opt for adapted local management protocols[ | Lack of training and supervision[ | |||
| Universal application[ | Lack of appropriate intervention[ | |||
| High rates of referral[ |
CTG = cardiotography, CS = caesarean, IA = Intermittent Auscultation, FBS = Foetal blood sampling, FHR = Foetal heart rate, FPO = Foetal pulse oximetry, MSAF = Meconium-staining amniotic fluid, rBPP = Rapid biophysical profile, SWOT = Strengths, Weaknesses, Opportunities, Threats, UADV = Umbilical artery Doppler velocity.